文献速递急性肾损伤慢性肾脏病

脓毒症相关急性肾脏病:发生率、预测与转归

Sepsis-Associated Acute Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2020-03-12

该研究基于一项纳入1341例脓毒症休克患者的大型随机试验数据,分析住院第1天合并2或3期急性肾损伤(AKI)的患者。598例中,26.9%发展为急性肾脏病(AKD),仅9.3%在出院前肾功能恢复;现有AKI生物标志物对AKD预测能力有限,NGAL仅小幅提升临床模型表现。

要点

  • 脓毒症休克合并中重度AKI患者中约四分之一发展为AKD。
  • AKD患者出院前肾功能恢复率仅9.3%,早期逆转者中14.2%复发。
  • 现有AKI生物标志物预测AKD能力有限,NGAL仅 modestly 改善临床模型。

核心结论

  • AKD在脓毒症休克患者中常见,尤其非裔美国男性和有基础CKD者,现有AKI生物标志物预测价值有限。

研究设计与样本

  • 基于一项纳入1341例脓毒症休克患者的大型随机试验数据,分析住院第1天2或3期AKI患者,AKD定义为肾小球滤过率持续降低>7天。

主要发现

  • 598例患者中119例(19.9%)7天内死亡,318例(53.2%)早期逆转,161例(26.9%)发生AKD。
  • 早期逆转者中45例(14.2%)复发AKI,仅约三分之一恢复;AKD患者仅15例(9.3%)出院前肾功能恢复。
  • AKD组男性、非裔美国人和基础CKD比例更高。
  • 所有检测的生物标志物预测AKD表现均不佳,NGAL仅小幅提升临床模型性能。

临床怎么用

  • 对脓毒症休克合并中重度AKI患者应警惕AKD发生,尤其非裔美国男性和基础CKD者。
  • 现有AKI生物标志物不推荐单独用于预测AKD,可考虑与临床变量联合使用。

局限性

  • 研究基于随机试验数据,AKD定义和生物标志物预测效能可能受特定人群和检测时序限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: About one-third of critically ill patients with acute kidney injury (AKI) develop persistently decreased kidney function, known as acute kidney disease (AKD), which may progress to chronic kidney disease (CKD). Although sepsis is the most common cause of AKI, little is known about sepsis-associated AKD. METHODS: Using data from a large randomized trial including 1341 patients with septic shock, we studied patients with stage 2 or 3 AKI on day 1 of hospitalization. We defined AKD as a persistently reduced glomerular filtration rate for >7 days. In addition to clinical data, we measured several urinary biomarkers (tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein 7 [TIMP-2∗IGFBP7], neutrophil gelatinase-associated lipocalin [NGAL], kidney injury molecule-1 [KIM-1], liver-type fatty acid binding protein, and type 4 collagen) at 0, 6, and 24 hours, to predict AKD. RESULTS: Of 598 patients, 119 (19.9%) died within 7 days, 318 (53.2%) had early reversal of AKI within the first 7 days, whereas 161 (26.9%) developed AKD. In patients with early reversal, 45 (14.2%) had relapsed AKI after early reversal, and only about one-third of these recovered. Among patients developing AKD, only 15 (9.3%) recovered renal function prior to discharge. Male sex, African American race, and underlying CKD were more predominant in patients developing AKD. None of the biomarkers tested performed well for prediction of AKD, although NGAL modestly increased the performance of a clinical model. CONCLUSIONS: AKD is common in patients with septic shock, especially among African American males and those with underlying CKD. Existing AKI biomarkers have limited utility for predicting AKD but might be useful together with clinical variables. Novel predictive biomarkers for renal recovery are needed.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Peerapornratana S, Priyanka P, Wang S, et al. Sepsis-Associated Acute Kidney Disease. Kidney Int Rep. 2020. PMID: 32518866. doi:10.1016/j.ekir.2020.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。